PL2681219T3 - Pochodne 6,7-dihydropirazolo[1,5-a]pirazyn-4-yloaminowe jako inhibitory beta-sekretazy (BACE) - Google Patents

Pochodne 6,7-dihydropirazolo[1,5-a]pirazyn-4-yloaminowe jako inhibitory beta-sekretazy (BACE)

Info

Publication number
PL2681219T3
PL2681219T3 PL12707276T PL12707276T PL2681219T3 PL 2681219 T3 PL2681219 T3 PL 2681219T3 PL 12707276 T PL12707276 T PL 12707276T PL 12707276 T PL12707276 T PL 12707276T PL 2681219 T3 PL2681219 T3 PL 2681219T3
Authority
PL
Poland
Prior art keywords
bace
secretase
pyrazin
pyrazolo
dihydro
Prior art date
Application number
PL12707276T
Other languages
English (en)
Inventor
Andrés Avelino Trabanco-Suárez
Henricus Jacobus Maria Gijsen
Gool Michiel Luc Maria Van
Ramiro Juan Antonio Vega
Francisca Delgado-Jiménez
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL2681219T3 publication Critical patent/PL2681219T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL12707276T 2011-03-01 2012-02-29 Pochodne 6,7-dihydropirazolo[1,5-a]pirazyn-4-yloaminowe jako inhibitory beta-sekretazy (BACE) PL2681219T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11156463 2011-03-01
PCT/EP2012/053455 WO2012117027A1 (en) 2011-03-01 2012-02-29 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
EP12707276.7A EP2681219B1 (en) 2011-03-01 2012-02-29 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)

Publications (1)

Publication Number Publication Date
PL2681219T3 true PL2681219T3 (pl) 2016-03-31

Family

ID=45808845

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12707276T PL2681219T3 (pl) 2011-03-01 2012-02-29 Pochodne 6,7-dihydropirazolo[1,5-a]pirazyn-4-yloaminowe jako inhibitory beta-sekretazy (BACE)

Country Status (27)

Country Link
US (1) US9346811B2 (pl)
EP (1) EP2681219B1 (pl)
JP (1) JP5853033B2 (pl)
KR (1) KR102012671B1 (pl)
CN (1) CN103415519B (pl)
AU (1) AU2012222394B2 (pl)
BR (1) BR112013022039A2 (pl)
CA (1) CA2824360C (pl)
CL (1) CL2013002486A1 (pl)
CO (1) CO6751282A2 (pl)
CY (1) CY1117663T1 (pl)
DK (1) DK2681219T3 (pl)
EA (1) EA022649B1 (pl)
ES (1) ES2558779T3 (pl)
HK (1) HK1188784A1 (pl)
HR (1) HRP20160030T1 (pl)
HU (1) HUE026338T2 (pl)
IL (1) IL228158A (pl)
MX (1) MX338333B (pl)
MY (1) MY161407A (pl)
PL (1) PL2681219T3 (pl)
PT (1) PT2681219E (pl)
SG (1) SG192963A1 (pl)
SI (1) SI2681219T1 (pl)
UA (1) UA109800C2 (pl)
WO (1) WO2012117027A1 (pl)
ZA (1) ZA201306545B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103936690B (zh) 2005-10-25 2016-06-08 盐野义制药株式会社 氨基二氢噻嗪衍生物
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
MX2009011498A (es) 2007-04-24 2009-11-10 Shionogi & Co Derivados de aminodihidrotiazina sustituida con un grupo ciclico.
KR20130018370A (ko) 2008-06-13 2013-02-20 시오노기세야쿠 가부시키가이샤 β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
JPWO2010047372A1 (ja) 2008-10-22 2012-03-22 塩野義製薬株式会社 Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
WO2011071135A1 (ja) 2009-12-11 2011-06-16 塩野義製薬株式会社 オキサジン誘導体
KR101730937B1 (ko) 2010-06-09 2017-04-27 얀센 파마슈티카 엔.브이. 베타-세크레타아제(ｂａｃｅ) 저해제로 유용한 5,6-디하이드로-2ｈ-[1,4]옥사진-3-일-아민 유도체
EP2634188A4 (en) 2010-10-29 2014-05-07 Shionogi & Co FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
US8927721B2 (en) 2010-10-29 2015-01-06 Shionogi & Co., Ltd. Naphthyridine derivative
SG191097A1 (en) 2010-12-22 2013-08-30 Janssen Pharmaceutica Nv 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
SG192841A1 (en) 2011-03-01 2013-09-30 Nucana Biomed Ltd Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
KR102012671B1 (ko) 2011-03-01 2019-08-21 얀센 파마슈티카 엔.브이. 베타-세크레타제(BACE)의 억제제로서 유용한 6,7-디하이드로-피라졸로[1,5-a]피라진-4-일아민 유도체
MX340031B (es) 2011-03-09 2016-06-21 Janssen Pharmaceutica Nv Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1-ilamina utiles como inhibidores de beta-secretasa (bace).
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
EA032662B1 (ru) 2013-06-12 2019-06-28 Янссен Фармацевтика Нв ПРОИЗВОДНЫЕ 4-АМИНО-6-ФЕНИЛ-5,6-ДИГИДРОИМИДАЗО[1,5-а]ПИРАЗИН-3(2H)-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ БЕТА-СЕКРЕТАЗЫ (BACE)
AU2014280124B2 (en) * 2013-06-12 2018-11-01 Janssen Pharmaceutica Nv 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (BACE)
CN105324383B (zh) * 2013-06-12 2017-10-31 詹森药业有限公司 作为β‑分泌酶(BACE)抑制剂的4‑氨基‑6‑苯基‑6,7‑二氢[1,2,3]三唑并[1,5‑A]吡嗪衍生物
CA2967164A1 (en) 2014-12-18 2016-06-23 Janssen Pharmaceutica Nv 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
TWI782056B (zh) * 2017-07-14 2022-11-01 日商鹽野義製藥股份有限公司 具有ｍｇａｔ２抑制活性的縮合環衍生物
WO2023243616A1 (ja) * 2022-06-13 2023-12-21 塩野義製薬株式会社 ジヒドロピリジノン誘導体またはその溶媒和物の結晶

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188389A (en) 1978-11-03 1980-02-12 Ayerst Mckenna & Harrison, Inc. 1,2,3,4-Tetrahydropyrrolo(1,2-A)pyrazines
TW224974B (pl) 1991-07-02 1994-06-11 Hoffmann La Roche
BR0309398A (pt) 2002-04-19 2005-02-01 Cellular Genomics Inc Composto ou um seu sal, hidrato, solvato, forma cristalina, diastereÈmero, prodroga farmaceuticamente aceitável, ou misturas deles, composição farmacêutica, e, métodos para tratar uma condição envolvida com a cinase em um mamìfero, para tratar câncer, e para identificar uma cinase
EP1543008B1 (en) 2002-09-23 2007-11-07 Schering Corporation Imidazopyrazines as cyclin dependent kinase inhibitors
AU2003297431A1 (en) 2002-12-20 2004-07-22 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
US7674791B2 (en) * 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
DK1678172T3 (da) 2003-10-15 2010-04-06 Targacept Inc Azabicykliske forbindelser til lindring af smerte og behandling af sygdomme i centralnervesystemet
JP2007533740A (ja) 2004-04-22 2007-11-22 イーライ リリー アンド カンパニー Ｂａｃｅ阻害剤としてのアミド
EP1756087B1 (en) 2004-06-16 2009-10-07 Wyeth Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
PE20060692A1 (es) 2004-09-21 2006-07-19 Lilly Co Eli Inhibidores bace
WO2006076284A2 (en) * 2005-01-14 2006-07-20 Wyeth AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASE
US20070005404A1 (en) 2005-06-09 2007-01-04 Drive Diagnostics Ltd. System and method for providing driving insurance
ES2436795T3 (es) 2005-06-14 2014-01-07 Merck Sharp & Dohme Corp. Inhibidores heterocíclicos de aspartil proteasa, preparación y uso de los mismos
AU2006266167A1 (en) 2005-06-30 2007-01-11 Wyeth Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
CN103936690B (zh) 2005-10-25 2016-06-08 盐野义制药株式会社 氨基二氢噻嗪衍生物
TW200804290A (en) 2005-11-15 2008-01-16 Astrazeneca Ab Compounds and uses thereof
JP2009532464A (ja) 2006-04-05 2009-09-10 アストラゼネカ・アクチエボラーグ ２−アミノピリミジン−４−オン及びＡβ−関連の病理を治療又は予防するためのその使用
GB2443654A (en) 2006-05-30 2008-05-14 Matthew Emmerson Allen System for detecting and testing drivers who show abnormal driving behaviour.
CN101501040A (zh) * 2006-06-14 2009-08-05 阿斯利康(瑞典)有限公司 氨基-咪唑啉以及它们作为治疗认知缺损、阿尔茨海默病、神经变性和痴呆的药物的用途
US20080051420A1 (en) * 2006-06-14 2008-02-28 Astrazeneca Ab New Compounds 317
TW200815443A (en) * 2006-06-14 2008-04-01 Astrazeneca Ab Novel compounds I
MX2009011498A (es) 2007-04-24 2009-11-10 Shionogi & Co Derivados de aminodihidrotiazina sustituida con un grupo ciclico.
TW200902499A (en) 2007-05-15 2009-01-16 Astrazeneca Ab New compounds
EP2217592A1 (en) 2007-10-30 2010-08-18 Arena Pharmaceuticals, Inc. Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto
BRPI0906625A2 (pt) 2008-01-28 2015-07-14 Janssen Pharmaceutica Nv Derivados de tio-2-amino-quinolina-6-substituída úteis como inibidores da beta-secretase (bace)
US20090221612A1 (en) 2008-02-13 2009-09-03 Mitchell Scott A Certain substituted amides, method of making, and method of use thereof
TWI431004B (zh) 2008-05-02 2014-03-21 Lilly Co Eli Ｂａｃｅ抑制劑
WO2011002409A1 (en) * 2009-07-02 2011-01-06 Astrazeneca Ab 5h-pyrrolo[3,4-£>]pyrazin-7-amine derivatives inhibitors of beta-secretase
UY32799A (es) * 2009-07-24 2011-02-28 Novartis Ag Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos
US8188079B2 (en) 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
US20120238557A1 (en) 2009-11-13 2012-09-20 Shionogi & Co., Ltd. Aminothiazine or aminooxazine derivative having amino linker
WO2011071135A1 (ja) 2009-12-11 2011-06-16 塩野義製薬株式会社 オキサジン誘導体
EP2518059A4 (en) 2009-12-24 2013-05-29 Shionogi & Co 4-AMINO-1,3-THIAZINE OR OXAZINE DERIVATIVE
PE20121640A1 (es) 2009-12-31 2012-12-17 Novartis Ag Derivados de pirazina como inhibidores de bace
KR101730937B1 (ko) 2010-06-09 2017-04-27 얀센 파마슈티카 엔.브이. 베타-세크레타아제(ｂａｃｅ) 저해제로 유용한 5,6-디하이드로-2ｈ-[1,4]옥사진-3-일-아민 유도체
EP2634188A4 (en) 2010-10-29 2014-05-07 Shionogi & Co FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
SG191097A1 (en) 2010-12-22 2013-08-30 Janssen Pharmaceutica Nv 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
US9242943B2 (en) 2011-01-18 2016-01-26 Siena Biotech S.P.A. 1,4 oxazines as BACE1 and/or BACE2 inhibitors
KR102012671B1 (ko) 2011-03-01 2019-08-21 얀센 파마슈티카 엔.브이. 베타-세크레타제(BACE)의 억제제로서 유용한 6,7-디하이드로-피라졸로[1,5-a]피라진-4-일아민 유도체
MX340031B (es) 2011-03-09 2016-06-21 Janssen Pharmaceutica Nv Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1-ilamina utiles como inhibidores de beta-secretasa (bace).
AU2012322329A1 (en) 2011-10-13 2014-05-01 Novartis Ag Novel oxazine derivatives and their use in the treatment of disease

Also Published As

Publication number Publication date
EP2681219A1 (en) 2014-01-08
IL228158A0 (en) 2013-11-25
NZ614551A (en) 2014-06-27
DK2681219T3 (en) 2016-01-18
EP2681219B1 (en) 2015-10-28
HRP20160030T1 (hr) 2016-02-12
AU2012222394A1 (en) 2013-07-25
KR20140010052A (ko) 2014-01-23
HK1188784A1 (zh) 2014-05-16
JP2014506907A (ja) 2014-03-20
CN103415519B (zh) 2016-03-02
EA022649B1 (ru) 2016-02-29
US20140005200A1 (en) 2014-01-02
CL2013002486A1 (es) 2014-02-21
CN103415519A (zh) 2013-11-27
BR112013022039A2 (pt) 2016-11-29
UA109800C2 (xx) 2015-10-12
MX338333B (es) 2016-04-11
US9346811B2 (en) 2016-05-24
SG192963A1 (en) 2013-09-30
EA201391251A1 (ru) 2014-01-30
SI2681219T1 (sl) 2016-02-29
PT2681219E (pt) 2016-02-10
CA2824360C (en) 2020-01-14
IL228158A (en) 2016-07-31
MY161407A (en) 2017-04-14
MX2013010040A (es) 2013-11-04
KR102012671B1 (ko) 2019-08-21
AU2012222394B2 (en) 2016-06-16
CY1117663T1 (el) 2017-05-17
ZA201306545B (en) 2015-03-25
CA2824360A1 (en) 2012-09-07
HUE026338T2 (en) 2016-05-30
ES2558779T3 (es) 2016-02-08
CO6751282A2 (es) 2013-09-16
JP5853033B2 (ja) 2016-02-09
WO2012117027A1 (en) 2012-09-07

Similar Documents

Publication Publication Date Title
IL228158A0 (en) History of 7,6-dihydro-pyrazolo[5,1-a]pyrazine-4-ylamine used as betascartase inhibitors
ZA201302128B (en) 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace)
IL228239A0 (en) Derivatives of 4,3-dihydro-pyrrolo[2.1-[a pyrazine-1-ylamine are effective as beta-saccharatase (bace) inhibitors
ZA201304646B (en) 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (bace)
ZA201209297B (en) 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
HK1189229A1 (zh) 三環吡咯並衍生物、它們的製備方法和它們作為激酶抑制劑的應用
EP2608669A4 (en) NEW PYRAZOLO- [1,5-A-] PYRIMIDINE DERIVATIVES AS ANTI-MTOR HEMMER
IL228590A0 (en) History of pyrrolo[3,2-d] pyrimidine as inhibitors of tropomyosin-linked kinases
ZA201209296B (en) 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
EP2710018B8 (en) Macrocyclic compounds as protein kinase inhibitors
ZA201307839B (en) Pyrazolo[4,3-d] pyrimidines useful as kinase inhibitors
EP2788000A4 (en) PYRROLOPYRIMIDINES AS INHIBITORS OF KINASE JANUS
ZA201303801B (en) Fused aminodihydrothiazine derivatives useful as bace inhibitors
IL229606A0 (en) Pyrazolone [3, 4-d] pyrimidine compounds and their use as 2pde inhibitors and/or 4a3 cyp inhibitors
EP2525659A4 (en) PYRAZOLO [1,5-A] PYRIMIDINES COMPOUNDS AS MTOR INHIBITORS
EP2661437A4 (en) 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO [2,3] PYRIMIDINE DERIVATIVES AS FAK / PYK2 INHIBITORS
CO6811848A2 (es) Derivados de (1,2,4) triazolo [4,3-a] quinoxalina como inhibidores de fosfodiesterasas
ZA201403441B (en) [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid
EP2739627A4 (en) 2,3-DIHYDROIMIDAZO [1,2-C] PYRIMIDIN-5 (1H) -ONE COMPOUNDS AND USE AS INHIBITORS OF LP-PLA2
ZA201105896B (en) [1,2,4] triazolo [1,5-a] pyridines as kinase inhibitors
ZA201407695B (en) Triazolo compounds as pde 10 inhibitors
IL229993A0 (en) A process for the preparation of 8-Alkoxy[1,2,4]triazolo[5,1-c]pyrimidine-2 amines 5-converted
ZA201306416B (en) Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
PL2694513T3 (pl) Pochodne pirazolopirymidynowe
EP2523552A4 (en) PYRAZOLO- [1,5-A] PYRIMIDINE AS MARK HEMMER